How to Buy Viracta Therapeutics Stock
Viracta Therapeutics Inc
Viracta Therapeutics, Inc. , a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies.
Viracta Therapeutics stock last closed at $0.86, down 5.72% from the previous day, and has decreased 35.08% in one year. It has underperformed other stocks in the Biotechnology industry by 0.1 percentage points. Viracta Therapeutics stock is currently +99.3% from its 52-week low of $0.43, and -63.99% from its 52-week high of $2.38.
As of Apr 19, 2024, there are 39.27M VIRX shares outstanding. The market value of VIRX is $33.66M. In the past 24 hours, 52,613 VIRX shares were traded.
How to Buy Viracta Therapeutics Stock
Not sure how to invest in Viracta Therapeutics stock? Here's how.
- Choose where to buy Viracta Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Viracta Therapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Pick your payment method and add your info.
- Research Viracta Therapeutics stock: The Viracta Therapeutics ticker symbol is VIRX. Is Viracta Therapeutics stock a good investment? Should you buy shares of VIRX? How do VIRX's underlying business fundamentals look? Do top analysts think Viracta Therapeutics is a good buy? Why has VIRX's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if VIRX is a good stock to buy).
- Execute your VIRX purchase: Decide if you will purchase VIRX shares at the current market price or use a limit order to purchase VIRX stock at a specific price.
- Get notifications regarding your VIRX investment: Create a watchlist to watch your position in Viracta Therapeutics shares.
Step 1: Choose where to buy Viracta Therapeutics stock
You need an online brokerage account in order to access the NASDAQ market and buy VIRX stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro today.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal details so you are able to buy VIRX stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new trading account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've opened your account on app for stock market, you can securely and quickly fund your account:
Watch the video below to see the process of transferring funds into your new investment account.
Step 4: Research Viracta Therapeutics stock
Once you have selected the best place to buy Viracta Therapeutics stock, it's absolutely critical to evaluate their stock prior to investing, so you can wrap your head around the risk and upside.
Viracta Therapeutics stock data
Viracta Therapeutics Fundamentals
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on VIRX's stock page.
Is VIRX stock overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge VIRX's intrinsic value.
Using relative valuations metrics:
- VIRX may be undervalued based on its P/B ratio of 1.84x, relative to Biotechnology industry P/B ratio of 5.74x
You can access additional valuation analysis on VIRX's stock here.
A quick look at VIRX Financials
Passed Health Checks:
- There are more short-term assets than long-term liabilities on the VIRX balance sheet.
- Total VIRX debt is lower than 5 years ago, relative to shareholder equity.
- VIRX has cash burn of 40030000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the VIRX balance sheet.
Failed Health Checks:
- VIRX has a relatively high debt to equity ratio of 2.1.
- VIRX has $53.69M in cash and short term investments. This is not sufficient to cover its annual cash burn of $40.03M.
Is it a good time to buy Viracta Therapeutics stock, according to Wall Street analysts?
Out of 3 Wall Street analysts who track VIRX, the consensus analyst rating on Viracta Therapeutics is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Viracta Therapeutics stock forecast page.
VIRX Technical Indicators
Is VIRX Growing Revenue?
Last year, VIRX revenue was $0.00. During the past 5 year, VIRX's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 28.92%.
You can research VIRX's earnings and revenue performance here.
Latest Insiders Trades at VIRX
In the last year, executives and large shareholders at VIRX have bought more shares than they have sold.
Daniel R. Chevallard, CFO and COO of VIRX, was the latest VIRX insider to sell. They sold $2,492.46 worth of VIRX shares on Feb 27, 2024.
Learn more about who owns VIRX stock here.
Does VIRX provide a stable income stream?
No, Viracta Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about VIRX?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your VIRX purchase
There are two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific price limit, use a limit order.
Click the Open Trade button and your broker will place your order.
If you want more help with buying stocks on eToro, click the helpful video below:
Step 6: Get notifications regarding your VIRX investment
Now that you own some VIRX shares, you'll want to keep up with your new investment.
Add VIRX to a watchlist to track the most important metrics related to your VIRX stock.
VIRX Feed
How to Buy Stock in Viracta Therapeutics
To summarize, here are the 6 steps for buying Viracta Therapeutics stock:
- Choose where to buy Viracta Therapeutics stock
- Open a brokerage account
- Deposit funds into your investment account
- Research Viracta Therapeutics stock
- Execute your VIRX purchase
- Get notifications regarding your VIRX investment
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to monitor your new investment in Viracta Therapeutics, create a watchlist today.
Other "How To" Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.